Author:
Klotsman M,Weinberg C R,Davis K,Binnie C G,Hartmann K E
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference48 articles.
1. Verhamme KMC, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom M . Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care—The Triumph project. Eur Urol 2002; 42: 323–328.
2. Berry SJ, Coffey DS, Walsh PC, Ewing LL . The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–479.
3. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA et al. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol 1999; 162: 1301–1306.
4. Partin AW, Coffey DS . The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In: Walsh PC (ed) Campbell's Urology, 7th edn. W.B. Saunders Company: Philadelphia 1998; pp 1381–1402.
5. Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H et al. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res 1998; 58: 4497–4504.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献